|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Xu Y, Gong M, Wang Y, Yang Y, Liu S and
Zeng Q: Global trends and forecasts of breast cancer incidence and
deaths. Sci Data. 10(334)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ferlay J, Ervik M, Lam F, Laversanne M,
Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I and Bray F:
Global cancer observatory: Cancer today. Lyon, France:
International Agency for Research on Cancer, 2024. Available from:
https://gco.iarc.who.int/today, accessed
(15 February 2024).
|
|
4
|
Łukasiewicz S, Czeczelewski M, Forma A,
Baj J, Sitarz R and Stanisławek A: Breast cancer-epidemiology, risk
factors, classification, prognostic markers, and current treatment
strategies-an updated review. Cancers (Basel).
13(4287)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Youn HJ and Han W: A review of the
epidemiology of breast cancer in Asia: Focus on risk factors. Asian
Pac J Cancer Prev. 21:867–880. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Momenimovahed Z and Salehiniya H:
Epidemiological characteristics of and risk factors for breast
cancer in the world. Breast Cancer (Dove Med Press). 11:151–164.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Takaoka M and Miki Y: BRCA1 gene: Function
and deficiency. Int J Clin Oncol. 23:36–44. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Qin TT, Chen T, Zhang Q, Du HN, Shu YQ,
Luo K and Zhu LJ: Association between BRCA1 rs799917 polymorphism
and breast cancer risk: A meta-analysis of 19,878 subjects. Biomed
Pharmacother. 68:905–910. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yang M, Du X, Zhang F and Yuan S:
Association between BRCA1 polymorphisms rs799917 and rs1799966 and
breast cancer risk: A meta-analysis. J Int Med Res. 47:1409–1416.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhao H and Kong Z: Lack of association of
BRCA1 gene rs799917 polymorphism with cancer risk. Int J Clin Exp
Med. 10:15886–15895. 2017.
|
|
11
|
Xu GP, Zhao Q, Wang D, Xie WY, Zhang LJ,
Zhou H, Chen SZ and Wu LF: The association between BRCA1 gene
polymorphism and cancer risk: A meta-analysis. Oncotarget.
9:8681–8694. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wu H, Liu Y, Kang H, Xiao Q, Yao W, Zhao
H, Wang E and Wei M: Genetic variations in ABCG2 gene predict
breast carcinoma susceptibility and clinical outcomes after
treatment with anthracycline-based chemotherapy. Biomed Res Int.
2015(279109)2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ghafouri H, Ghaderi B, Amini S, Nikkhoo B,
Abdi M and Hoseini A: Association of ABCB1 and ABCG2 single
nucleotide polymorphisms with clinical findings and response to
chemotherapy treatments in Kurdish patients with breast cancer.
Tumour Biol. 37:7901–7906. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Al-Eitan LN, Rababa'h DM, Alghamdi MA and
Khasawneh RH: Role of Four ABC transporter genes in pharmacogenetic
susceptibility to breast cancer in Jordanian patients. J Oncol.
2019(6425708)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ren C, Zeng K, Wu C, Mu L, Huang J and
Wang M: Human papillomavirus infection increases the risk of breast
carcinoma: A large-scale systemic review and meta-analysis of
case-control studies. Gland Surg. 8:486–500. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Graham R, Gazinska P, Zhang B, Khiabany A,
Sinha S, Alaguthurai T, Flores-Borja F, Vicencio J, Beuron F,
Roxanis I, et al: Serum-derived extracellular vesicles from breast
cancer patients contribute to differential regulation of
T-cell-mediated immune-escape mechanisms in breast cancer subtypes.
Front Immunol. 14(1204224)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Khodabandehlou N, Mostafaei S, Etemadi A,
Ghasemi A, Payandeh M, Hadifar S, Norooznezhad AH, Kazemnejad A and
Moghoofei M: Human papilloma virus and breast cancer: The role of
inflammation and viral expressed proteins. BMC Cancer.
19(61)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kudela E, Kudelova E, Kozubík E, Rokos T,
Pribulova T, Holubekova V and Biringer K: HPV-associated breast
cancer: Myth or fact? Pathogens. 11(1510)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen ACH, Keleher A, Kedda MA, Spurdle AB,
McMillan NAJ and Antonsson A: Human papillomavirus DNA detected in
peripheral blood samples from healthy Australian male blood donors.
J Med Virol. 81:1792–1796. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pongpakdeesakul S, Ekalaksananan T,
Pientong C, Iamchuen N, Buddhisa S, Mahingsa K, Pingyod A,
Sangsrijun W, Passorn S, Chopjitt P, et al: Human oncogenic
epstein-barr virus in water and human blood infection of
communities in Phayao Province, Thailand. Water. 15(323)2023.
|
|
21
|
Sumala S, Ekalaksananan T, Pientong C,
Buddhisa S, Passorn S, Duangjit S, Janyakhantikul S, Suktus A and
Bumrungthai S: The association of HHV-6 and the TNF-α (-308G/A)
promotor with major depressive disorder patients and healthy
controls in Thailand. Viruses. 15(1898)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Słomka M, Sobalska-Kwapis M, Wachulec M,
Bartosz G and Strapagiel D: High resolution melting (HRM) for
high-throughput genotyping-limitations and caveats in practical
case studies. Int J Mol Sci. 18(2316)2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Eclov RJ, Kim MJ, Smith R, Ahituv N and
Kroetz DL: Rare variants in the ABCG2 promoter modulate in vivo
activity. Drug Metab Dispos. 46:636–642. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
de Roda Husman AM, Walboomers JM, van den
Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5
and GP6 elongated at their 3' ends with adjacent highly conserved
sequences improves human papillomavirus detection by PCR. J Gen
Virol. 76:1057–1062. 1995.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lilyquist J, Ruddy KJ, Vachon CM and Couch
FJ: Common genetic variation and breast cancer risk-past, present,
and future. Cancer Epidemiol Biomarkers Prev. 27:380–394.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Behravan H, Hartikainen JM, Tengström M,
Kosma VM and Mannermaa A: Predicting breast cancer risk using
interacting genetic and demographic factors and machine learning.
Sci Rep. 10(11044)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sartor H, Brandt J, Grassmann F, Eriksson
M, Czene K, Melander O and Zackrisson S: The association of single
nucleotide polymorphisms (SNPs) with breast density and breast
cancer survival: The Malmö diet and cancer study. Acta Radiol.
61:1326–1334. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yang H, Ting X, Geng YH, Xie Y, Nierenberg
JL, Huo YF, Zhou YT, Huang Y, Yu YQ, Yu XY, et al: The risk variant
rs11836367 contributes to breast cancer onset and metastasis by
attenuating Wnt signaling via regulating NTN4 expression. Sci Adv.
8(eabn3509)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sellers TA: Genetic factors in the
pathogenesis of breast cancer: Their role and relative importance.
J Nutr. 127 (5 Suppl):929S–932S. 1997.PubMed/NCBI View Article : Google Scholar
|
|
30
|
De Silva S, Tennekoon KH and Karunanayake
EH: Overview of the genetic basis toward early detection of breast
cancer. Breast Cancer (Dove Med Press). 11:71–80. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sokolova A, Johnstone KJ, McCart Reed AE,
Simpson PT and Lakhani SR: Hereditary breast cancer: Syndromes,
tumour pathology and molecular testing. Histopathology. 82:70–82.
2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wendt C and Margolin S: Identifying breast
cancer susceptibility genes-a review of the genetic background in
familial breast cancer. Acta Oncol. 58:135–146. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu
ZY, Shi W, Jiang J, Yao PP and Zhu HP: Risk factors and preventions
of breast cancer. Int J Biol Sci. 13:1387–1397. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hill AD, Doyle JM, McDermott EW and
O'Higgins NJ: Hereditary breast cancer. Br J Surg. 84:1334–1339.
1997.PubMed/NCBI
|
|
35
|
Collins A and Politopoulos I: The genetics
of breast cancer: Risk factors for disease. Appl Clin Genet.
4:11–19. 2011.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kumaran M, Cass CE, Graham K, Mackey JR,
Hubaux R, Lam W, Yasui Y and Damaraju S: Germline copy number
variations are associated with breast cancer risk and prognosis.
Sci Rep. 7(14621)2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Pan X, Hu X, Zhang YH, Chen L, Zhu L, Wan
S, Huang T and Cai YD: Identification of the copy number variant
biomarkers for breast cancer subtypes. Mol Genet Genomics.
294:95–110. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Dennis J, Tyrer JP, Walker LC, Michailidou
K, Dorling L, Bolla MK, Wang Q, Ahearn TU, Andrulis IL,
Anton-Culver H, et al: Rare germline copy number variants (CNVs)
and breast cancer risk. Commun Biol. 5(65)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhang W and Yu Y: The important molecular
markers on chromosome 17 and their clinical impact in breast
cancer. Int J Mol Sci. 12:5672–5683. 2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chen C, Lin CJ, Pei YC, Ma D, Liao L, Li
SY, Fan L, Di GH, Wu SY, Liu XY, et al: Comprehensive genomic
profiling of breast cancers characterizes germline-somatic mutation
interactions mediating therapeutic vulnerabilities. Cell Discov.
9(125)2023.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lertwilaiwittaya P, Roothumnong E,
Nakthong P, Dungort P, Meesamarnpong C, Tansa-Nga W, Pongsuktavorn
K, Wiboonthanasarn S, Tititumjariya W, Thongnoppakhun W, et al:
Thai patients who fulfilled NCCN criteria for breast/ovarian cancer
genetic assessment demonstrated high prevalence of germline
mutations in cancer susceptibility genes: Implication to Asian
population testing. Breast Cancer Res Treat. 188:237–248.
2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sukpan P, Sangkhathat S, Sriplung H,
Laochareonsuk W, Choochuen P, Auseng N, Khoonjan W, Salaeh R,
Thangnaphadol K, Wanawanakorn K and Kanokwiroon K: Exome sequencing
reveals novel germline variants in breast cancer patients in the
southernmost region of Thailand. J Pers Med.
13(1587)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Manchanda R, Patel S, Gordeev VS, Antoniou
AC, Smith S, Lee A, Hopper JL, MacInnis RJ, Turnbull C, Ramus SJ,
et al: Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C,
RAD51D, BRIP1, PALB2 mutation testing in unselected general
population women. J Natl Cancer Inst. 110:714–725. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Nicoloso MS, Sun H, Spizzo R, Kim H,
Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L,
et al: Single-nucleotide polymorphisms inside microRNA target sites
influence tumor susceptibility. Cancer Res. 70:2789–2798.
2010.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Smolarz B, Bryś M, Forma E, Zadrożny M,
Bieńkiewicz J and Romanowicz H: Data on single nucleotide
polymorphism of DNA repair genes and breast cancer risk from
Poland. Pathol Oncol Res. 25:1311–1317. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ahmad J, Le Calvez-Kelm F, Daud S, Voegele
C, Vallée M, Ahmad A, Kakar N, McKay JD, Gaborieau V, Léoné M, et
al: Detection of BRCA1/2 mutations in breast cancer patients from
Thailand and Pakistan. Clin Genet. 82:594–598. 2012.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Stiburkova B, Pavelcova K, Zavada J, Petru
L, Simek P, Cepek P, Pavlikova M, Matsuo H, Merriman TR and Pavelka
K: Functional non-synonymous variants of ABCG2 and gout risk.
Rheumatology (Oxford). 56:1982–1992. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Toyoda Y, Pavelcová K, Bohatá J, Ješina P,
Kubota Y, Suzuki H, Takada T and Stiburkova B: Identification of
two dysfunctional variants in the ABCG2 urate transporter
associated with pediatric-onset of familial hyperuricemia and
early-onset gout. Int J Mol Sci. 22(1935)2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Keskitalo JE, Zolk O, Fromm MF, Kurkinen
KJ, Neuvonen PJ and Niemi M: ABCG2 polymorphism markedly affects
the pharmacokinetics of atorvastatin and rosuvastatin. Clin
Pharmacol Ther. 86:197–203. 2009.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Phan L, Jin H, Zhang W, Qiang E, Shekhtman
D, Shao D, Revoe R, Villamarin E, Ivanchenko M, Kimura ZY, et al:
‘ALFA: Allele frequency aggregator’. national center for
biotechnology information, U.S. National Library of Medicine, 10
Mar, 2020. www.ncbi.nlm.nih.gov/snp/docs/gsr/alfa/.
|
|
51
|
Bircsak KM, Moscovitz JE, Wen X, Archer F,
Yuen PYS, Mohammed M, Memon N, Weinberger BI, Saba LM, Vetrano AM,
et al: Interindividual regulation of the breast cancer resistance
protein/ABCG2 transporter in term human placentas. Drug Metab
Dispos. 46:619–627. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Ngamkham J, Karalak A, Chaiwerawattana A,
Sornprom A, Thanasutthichai S, Sukarayodhin S, Mus-u-Dee M,
Boonmark K, Phansri T and Laochan N: Prevalence of human
papillomavirus infection in breast cancer cells from Thai women.
Asian Pac J Cancer Prev. 18:1839–1845. 2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Bumrungthai S, Ekalaksananan T, Duangchai
D, Lanpol P, Panya P, Kattiwong F, Acharya S and Pientong C:
Prevalence of human papillomavirus in oral rinse samples from
healthy individuals in northern Thailand. J Oral Pathol Med.
48:159–165. 2019.PubMed/NCBI View Article : Google Scholar
|
